These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34016620)

  • 1. A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome.
    Parquin F; Zuber B; Vallée A; Taupin JL; Cuquemelle E; Malard S; Neuville M; Devaquet J; Le Guen M; Fessler J; Beaumont L; Picard C; Hamid A; Colin de Verdière S; Grenet D; De Miranda S; Glorion M; Sage E; Pricopi C; De Wolf J; Brun AL; Longchampt E; Cerf C; Roux A; Brugière O
    Eur Respir J; 2021 Nov; 58(5):. PubMed ID: 34016620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative outcomes of lung transplant recipients with preformed donor-specific antibodies.
    Kayawake H; Chen-Yoshikawa TF; Gochi F; Tanaka S; Yurugi K; Hishida R; Yutaka Y; Yamada Y; Ohsumi A; Hamaji M; Nakajima D; Date H
    Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):616-624. PubMed ID: 33351064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch.
    Abdulqawi R; Alawwami M; Aldosari O; Aldosari Z; Alhuqbani M; Saleh RA; Esendagli D; Aldakhil H; De Vol EB; Alkattan K; Marquez KAH; Saleh W; Sandoqa S; Al-Mutairy EA
    Clin Transplant; 2024 Jul; 38(7):e15374. PubMed ID: 38979724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.
    Verleden SE; Vanaudenaerde BM; Emonds MP; Van Raemdonck DE; Neyrinck AP; Verleden GM; Vos R
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.
    Shino MY; Zhang Q; Li N; Derhovanessian A; Ramsey A; Saggar R; Britton IN; Amubieya OO; Lari SM; Hickey M; Reed EF; Noble PW; Stripp BR; Fishbein GA; Lynch JP; Ardehali A; Sayah DM; Weigt SS; Belperio JA
    Am J Transplant; 2022 Feb; 22(2):565-573. PubMed ID: 34464505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.
    Brugière O; Roux A; Le Pavec J; Sroussi D; Parquin F; Pradère P; Dupin C; Bunel V; Mourin G; Jebrak G; Dauriat G; Castier Y; Mordant P; Lortat-Jacob B; Jean-Baptiste S; Mal H; Suberbielle C; Gautreau C; Caillat-Zucman S; Cazes A; Thabut G; Taupin JL
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29976654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fraction of sensitization among lung transplant recipients in a transplant center in Japan.
    Kumata S; Hirama T; Watanabe Y; Oishi H; Niikawa H; Akiba M; Tikkanen J; Okada Y
    BMC Pulm Med; 2020 Oct; 20(1):256. PubMed ID: 33008353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients.
    Razia D; Hu C; Cherrier L; Nasar A; Walia R; Tokman S
    Transpl Immunol; 2022 Dec; 75():101703. PubMed ID: 36049718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infection correlates with high MFI donor-specific antibody development following lung transplantation with consequential graft loss and shortened CLAD-free survival.
    Bogyó LZ; Török K; Illés Z; Szilvási A; Székely B; Bohács A; Pipek O; Madurka I; Megyesfalvi Z; Rényi-Vámos F; Döme B; Bogos K; Gieszer B; Bakos E
    Respir Res; 2024 Jul; 25(1):262. PubMed ID: 38951782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
    Courtwright AM; Cao S; Wood I; Mallidi HR; Kawasawa J; Moniodis A; Ng J; El-Chemaly S; Goldberg HJ
    Ann Am Thorac Soc; 2019 Sep; 16(9):1131-1137. PubMed ID: 31026404
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation.
    Peräsaari JP; Kyllönen LE; Salmela KT; Merenmies JM
    Nephrol Dial Transplant; 2016 Apr; 31(4):672-8. PubMed ID: 26614272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.
    Lai C; Newman A; Mawson J; Abou-Daher F; Watson N; Majumdar A; Wyburn K; Chadban S; Gracey D
    BMC Nephrol; 2020 Feb; 21(1):47. PubMed ID: 32050922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.
    Michielsen LA; Wisse BW; Kamburova EG; Verhaar MC; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; van Zuilen AD
    Nephrol Dial Transplant; 2019 Jun; 34(6):1056-1063. PubMed ID: 30365008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation.
    Gochi F; Chen-Yoshikawa TF; Kayawake H; Ohsumi A; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Hamaji M; Yurugi K; Hishida R; Date H
    J Heart Lung Transplant; 2021 Jul; 40(7):607-613. PubMed ID: 34078558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?
    Vacha M; Chery G; Hulbert A; Byrns J; Benedetti C; Finlen Copeland CA; Gray A; Onwuemene O; Palmer SM; Snyder LD
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 27988971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression.
    Courtwright AM; Kamoun M; Diamond JM; Kearns J; Ahya VN; Christie JD; Clausen E; Hadjiliadis D; Patel N; Salgado JC; Cevasco M; Cantu EE; Crespo MM; Bermudez CA
    Clin Transplant; 2021 Nov; 35(11):e14447. PubMed ID: 34365656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung intragraft donor-specific antibodies as a risk factor for graft loss.
    Visentin J; Chartier A; Massara L; Linares G; Guidicelli G; Blanchard E; Parrens M; Begueret H; Dromer C; Taupin JL
    J Heart Lung Transplant; 2016 Dec; 35(12):1418-1426. PubMed ID: 27450460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.